Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Antitrust Trouble For Turing? NY Opens Probe

This article was originally published in Scrip

Executive Summary

The negative publicity Turing Pharmaceuticals AG has been garnering over the past month for its nearly 5,500% increase of its toxoplasmosis medicine Daraprim (pyrimethamine), which quickly became a presidential election issue, has now grabbed the attention of antitrust investigators in New York.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register